Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Cannula Market Size

ID: MRFR//5472-HCR | 90 Pages | Author: Rahul Gotadki| May 2024

The cannula market is expected to expand at a CAGR of 6.7% from 2018 to 2030, and it is expected to reach $286.4 billion in terms of total market value.

Many important factors determine the dynamics and development trajectory of the cannula market. The rise in chronic diseases and resultant surgeries is one of such drivers for this industry. Medical procedures requiring cannulation like intravenous administration, oxygen therapy as well as other medical emergencies are rising due to global ageing population and increased prevalence of lifestyle-related health problems.

The cannula market also greatly depends on technological advances. Manufacturing, design, and material science have led to better and more user-friendly cannulas. Cannula performance, patient comfort as well as complication rates are positively influenced by these technological advancements thus driving forward healthcare providers/institutions that are willing to utilize state-of-the-art technologies.

Also contributing to its advancement is an increasing level of public awareness about healthcare issues at large. Cannulas have grown popular with patients paying closer attention being given towards understanding their benefits among other reasons. Cannulas among other medical interventions are subject to input from patients because people now know better why they should take part in making decisions concerning healthcare.

Economic factors play a very significant role in defining the sensitivity level of the cannula market.In relation to global economic growth depending on what each region’s health infrastructure plus spending capability looks like. Surgical operations are on the rise with access to medical facilities in developing nations due to an increase in health spending. Cannulas, therefore, enjoy high demand. On the other hand, during tough economic times healthcare spending is reduced giving less funds for innovative devices such as cannulas.

The dynamics of the cannula market are influenced by many competitive variables, including healthcare sector mergers, acquisitions, and partnerships. In order to diversify their product portfolios, improve their technical skills and gain an edge in the market place; companies seek strategic alliances. These strategic moves also affect how market penetration as well as pricing tactics of a given industry make up its market structure.

Cannula Market Overview 


Cannula Market size is expected to reach USD 286.4 billion by 2030 at CAGR 6.7% during the forecast period 2022-2030, says market research future (MRFR). A cannula is a small hollow tube with a sharpened and retractable inner core that is inserted into a vein, artery, or body cavity to deliver medication and remove fluids. Cannulae are available for a range of procedures. During heart surgery, for example, an intravenous cannula is used to achieve cardiopulmonary bypass. A nasal cannula is used to supply oxygen by placing the plastic tubing behind the nose. It's also commonly used for filler injections because it's less painful, reduces the danger of bleeding and bruising, and has more flexibility than hypodermic needles. It is frequently utilized in hospitals, ambulatory surgery centers (ASCs), blood banks, laboratories, and pathology laboratories all over the world due to its many qualities. The growing number of surgeries, innovations in healthcare facilities, more investment in research & development, a large patient pool, and rising government funding are the major factors driving this market. A primary driver of this business is the expanding usage of minimally invasive surgery (MIS) therapies.

Segmentation: The Cannula market has been segmented into product, material, application and end user. The market, on the basis of product, has been segmented into cardiac cannulas, nasal cannulas, vascular cannulas, dermatology cannulas, arthroscopy cannulas and others.The market, by material, has been segmented into plastic (PVC), silicone and metal (stainless steel).The market, by application, has been segmented into cardiovascular surgery, oxygen therapy, general surgery, plastic/cosmetic surgery, orthopaedic surgery and others. The market, by end user, has been segmented into hospitals, ambulatory surgical centers and others. The hospitals segment is anticipated to hold the largest market share owing to increase in hospitalizations and large number of surgeries in hospitals. The ambulatory surgical centers are expected to grow at the highest CAGR owing to the increasing demand for modern healthcare facilities.The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Cannula Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European Market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Cannula market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key players: Medtronic, Edwards Lifesciences Corporation, Terumo Cardiovascular Systems Corporation, LivaNova PLC, Smith & Nephew, CONMED Corporation, Smiths Medical, Teleflex Incorporated, Boston Scientific Corporation, McKesson Medical-Surgical Inc., Harsoria Healthcare Pvt. Ltd., ISPG Inc., ILIFE MEDICAL DEVICES PRIVATE LIMITED (INDIA), Denex International, BD and others are some of the key players in the Cannula market.


Regional Market Summary


Geographically, the Americas is anticipated to dominate the Cannula market owing to rising healthcare expenditure, increase in number of surgeries and developing healthcare infrastructure. According to Centers Medicare and Medicaid Services, National Healthcare Expenditure grew by 4.3% to USD 3.3 trillion in 2016 from the previous year. Europe is expected to hold the second largest position in the market. The market growth in this region is attributed to the government support and improving healthcare related research & development activities. The Cannula Market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the increasing demand for minimally invasive surgeries and rising healthcare spending. According to the World Bank Group, India spent 3.89% of its Gross Domestic Product (GDP) on health. The Middle East & Africa are expected to hold the least share of the market. The market growth in this region is expected to be driven by a developing healthcare infrastructure.Recent Development


LivaNova announced Bi-Flow, a novel range of femoral artery cannulas that allows stable bidirectional perfusion and is the only femoral arterial cannula that prevents limb ischemia, in July 2019. Europe and Canada are among the markets where this new equipment is accessible. In addition, the corporation plans to extend its market in the United States, thereby boosting its industry share. Terumo Blood and Cell Technologies' (Terumo BCT) unique plasma collection technology was authorized by the US Food and Drug Administration (FDA) in March 2022. Terumo BCT is a medical technology company that leads the cannula market. Rika is a next-generation automated technology designed to improve the experience of plasma facility employees and donors. Rika was founded in response to the industry's need for technological advancement and process optimization to boost productivity and quality while maintaining donor safety and a sufficient plasma supply.

Market of Cannula, by Product:



  •       Cardiac Cannulas

  •       Nasal Cannulas

  •       Vascular Cannulas

  •       Dermatology Cannulas

  •       Arthroscopy Cannulas

  •       Others


Market of Cannula, by Material



  •       Plastic (PVC)

  •       Silicone

  •       Metal (Stainless Steel)


Market of Cannula, by Application



  •       Cardiovascular Surgery

  •       Oxygen Therapy

  •       General Surgery

  •       Cosmetic/Plastic Surgery

  •       Orthopedic Surgery

  •       Others 


Market of Cannula, by End User



  •        Hospitals

  •        Ambulatory Surgical Centers

  •        Others


Market of Cannula, by Region:



  • Americas


    •  North America


      •    US

      •   Canada


    •  South America


  • Europe


    •  Western Europe


      •   Germany

      •   France

      •    Italy

      •   Spain

      •   UK

      •   Rest of Western Europe


    •  Eastern Europe


  • Asia-Pacific


    •  Japan

    •  China

    •  India

    •  Australia

    •  South Korea

    • Rest of Asia-Pacific


  • The Middle East & Africa


    •  Middle East

    •  Africa



Cannula Market, by Key Players:



  •        Medtronic

  •        Edwards Lifesciences Corporation

  •        Terumo Cardiovascular Systems Corporation

  •         LivaNova PLC

  •        Smith & Nephew

  •        CONMED Corporation

  •        Smiths Medical

  •        Teleflex Incorporated

  •        Boston Scientific Corporation

  •        McKesson Medical-Surgical Inc.

  •        Harsoria Healthcare Pvt. Ltd.

  •        ISPG Inc.

  •        ILIFE MEDICAL DEVICES PRIVATE LIMITED (INDIA)

  •        Denex International

  •        BD


Intended Audience:




  • Medical Device Suppliers

  • Research and Development Organization

  • Medical Device Manufacturers

  • Healthcare Organizations

  • Academics and Research Institutes

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.